Unlock instant, AI-driven research and patent intelligence for your innovation.

Fluorescent probe for anticancer platinum prodrug reduction activation as well as preparation method and application thereof

A fluorescent probe and prodrug technology, applied in the field of biochemistry, can solve the problems of different cisplatin and changing the uptake characteristics of pharmacophore

Active Publication Date: 2020-11-03
HUNAN NORMAL UNIVERSITY
View PDF4 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, modification of Pt(IV) complexes with such bulky organic groups alters the pharmacophores and their uptake properties, making them different from cisplatin

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Fluorescent probe for anticancer platinum prodrug reduction activation as well as preparation method and application thereof
  • Fluorescent probe for anticancer platinum prodrug reduction activation as well as preparation method and application thereof
  • Fluorescent probe for anticancer platinum prodrug reduction activation as well as preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035] A preparation method of a fluorescent probe capable of detecting platinum (II) (cisplatin), the synthetic route is as follows figure 1 As shown, it specifically includes the following steps:

[0036] (1) In a two-necked round-bottomed flask equipped with magnets, add rhodamine 6G 0.480 g, 1.0 mmol, hydroxylamine hydrochloride 0.140 g, 2.0 mmol, potassium carbonate 0.276 g, 2.0 mmol and DMF 3.0 mL. 25 o C for 12 h. The reaction mixture was poured into saturated brine, the solid was collected by filtration, and dried to obtain the crude rhodamine 6G hydroxamic acid, which was then separated by column chromatography, methanol / ethyl acetate=1:4, v / v, R f =0.6, rhodamine 6G hydroxamic acid was obtained, and the productive rate was 95.0%.

[0037] (2) Dissolve 220 mg, 0.48 mmol of rhodamine 6G hydroxamic acid in 2 mL of DMF, and add 671 μL, 4.81 mmol of triethylamine and 829 μL, 9.62 mmol of 1,2-dibromoethane. The reaction mixture was heated at 60 o C under reflux for 4 ...

Embodiment 2

[0040] A method for preparing a fluorescent probe capable of detecting platinum (II) (cisplatin), using DMSO as a solvent to synthesize a fluorescent molecular probe (1), comprising the following steps:

[0041] (1) In a two-necked round-bottomed flask equipped with magnets, add rhodamine 6G 0.480 g, 1.0 mmol, hydroxylamine hydrochloride 0.140 g, 2.0 mmol, potassium carbonate 0.276 g, 2.0 mmol, and DMSO 3.0 mL. 25 o C was reacted for 11 h. The reaction mixture was poured into saturated brine, the solid was collected by filtration, and dried to obtain the crude rhodamine 6G hydroxamic acid, which was then separated by column chromatography, methanol / ethyl acetate=1:4, v / v, R f =0.6, rhodamine 6G hydroxamic acid was obtained, and the yield was 94.5%.

[0042] (2) Dissolve 220 mg, 0.48 mmol of rhodamine 6G hydroxamic acid in 2 mL of DMSO, and add 1004 μL of triethylamine, 7.20 mmol and 1034 μL, 12 mmol of 1,2-dibromoethane. The reaction mixture was heated at 80 o C under refl...

Embodiment 3

[0045] A method for preparing a fluorescent probe capable of detecting platinum (II) (cisplatin), using DMA as a solvent to synthesize a fluorescent molecular probe (1), comprising the following steps:

[0046] (1) In a two-necked round-bottomed flask equipped with magnets, add rhodamine 6G 0.480 g, 1.0 mmol, hydroxylamine hydrochloride 0.140 g, 2.0 mmol, potassium carbonate 0.276 g, 2.0 mmol, and DMA 3.0 mL. 25 o C for 10 h. The reaction mixture was poured into saturated brine, the solid was collected by filtration, and dried to obtain the crude rhodamine 6G hydroxamic acid, which was then separated by column chromatography, methanol / ethyl acetate=1:4, v / v, R f =0.6, rhodamine 6G hydroxamic acid was obtained, and the yield was 93.7%.

[0047] (2) Dissolve 220 mg, 0.48 mmol of rhodamine 6G hydroxamic acid in DMA 2 mL, and add 468 μL, 3.36 mmol of triethylamine and 620 μL, 7.20 mmol of 1,2-dibromoethane. The reaction mixture was heated at 70 o C under reflux for 5 h. The s...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention synthesizes a preparation method and application of a fluorescent probe for researching reduction activation of an anti-cancer platinum (IV) prodrug based on a cis-platinum stent. The probe can specifically detect and identify platinum (II) (cis-platinum), and the structural formula of the probe is shown as (1). The probe specially used for detecting the platinum (II) drug is designed by utilizing the difference of reactivity between a platinum IV prodrug and a platinum (II) homolog thereof. According to the probe, rhodamine 6G hydroxamic acid is used as a fluorescent group, anddithiocarbamate is used as a recognition group. The dithiocarbamate can specifically recognize platinum (II) without being interfered by other biomolecules, ions, bacteria and the like. The probe hasimportant scientific research and application values for researching reduction activation of the anticancer platinum (IV) prodrug based on the cis-platinum stent. The formula (1) is shown in the specification.

Description

technical field [0001] The invention belongs to the technical field of biochemistry, and in particular relates to a novel fluorescent molecular probe for detecting the reductive activation of anti-cancer platinum (IV) prodrug, its preparation method and application. Background technique [0002] The threat of cancer to humans is becoming more and more serious, so the research on anticancer drugs has attracted more and more attention from scholars. After its potent antitumor activity was discovered in 1965, the inorganic drug cisplatin has become one of the most clinically important anticancer drugs and can be used to treat bladder cancer, ovarian cancer, lung cancer, etc. Its success led to the development of second-generation drugs, carboplatin and oxaliplatin, both also based on the cisplatin(II) pharmacophore, and together these FDA-approved Pt(II) drugs make up some The most widely used chemotherapy drug. However, although these Pt(II) drugs are effective against cance...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D491/107C09K11/06G01N21/64
CPCC07D491/107C09K11/06G01N21/6428C09K2211/1033Y02P20/55
Inventor 张友玉吴萃艳李佩娟李雅倩李海涛
Owner HUNAN NORMAL UNIVERSITY